ARAN - Access to Research at NUI Galway

Clinical Applications of Molecular Profiling in Colorectal Cancer

ARAN - Access to Research at NUI Galway

Show simple item record

dc.contributor.advisor Miller, Nicola
dc.contributor.advisor Kerin, Michael J.
dc.contributor.author Kheirelseid, Elrasheid Ahmed Hassan
dc.date.accessioned 2012-09-04T08:20:07Z
dc.date.available 2012-09-04T08:20:07Z
dc.date.issued 2011-06
dc.identifier.uri http://hdl.handle.net/10379/2961
dc.description.abstract Despite developments in diagnosis and treatment, 20% of colorectal cancer (CRC) patients present with metastatic disease and 30% of cases recur after curative surgery. Furthermore, the molecular factors involved in prognosis and response to therapy in CRC are poorly understood. The objectives of this study were to examine the expression patterns of candidate miRNAs and mRNAs and proteins in CRC in order to identify molecular biomarkers for disease classification and prognostication. Expression patterns of miRNA and mRNA species were determined in FFPE and fresh colorectal tissues by microarray analysis and real-time quantitative PCR. Protein expression was determined by immunohistochemistry. Statistical analysis and correlation with clinicopathological data was performed using SPSS software. MiRNA signatures predictive of response of rectal cancer to neoadjuvant therapy were determined. Expression levels of CXCL12 (p=0.000), CDH17 (P=0.026), MUC2 (p=0.000), L-FABP (p=0.000) and PDCD4 (p=0.000) were down regulated and IL8 (p=0.000) was upregulated in tumours compared to normal colorectal tissues. Moreover, significant associations of gene expression levels and clinicopathological variables such as tumour size, grade, invasion and lymph node status were identified. Of further interest, significant miRNA/mRNA correlations were also determined in this study. A comprehensive list of biomarkers with highly differential expression patterns in colorectal cancer that could serve as molecular markers to complement existing histopathological factors in diagnosis, follow up and therapeutic strategies for individualised care of patients. Furthermore, the significant miRNA/mRNA correlations highlight important novel mechanisms in CRC initiation and progression. en_US
dc.subject Colorectal cancer en_US
dc.subject Molecular profiling en_US
dc.subject Gene expression en_US
dc.title Clinical Applications of Molecular Profiling in Colorectal Cancer en_US
dc.type Thesis en_US
dc.contributor.funder National Breast Cancer Research Institute en_US
dc.local.note We identified a comprehensive list of markers for colorectal cancer that can serve as markers to complement existing histopathological factors in diagnosis, follow up and therapeutic strategies for individualised care of patients. Furthermore, the significant miRNA/mRNA correlations highlight important novel mechanisms in CRC initiation and progression. en_US
dc.local.final Yes en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record